A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
Clinical trial NCT05675449 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05675449
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-14
- Primary completion
- 2026-03-11
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.